Dutee Chand gets four-year ban for failing dope test

Dutee Chand gets four-year ban for failing dope test

Daily Current Affairs   /   Dutee Chand gets four-year ban for failing dope test

Change Language English Hindi

Category : Sports Published on: August 19 2023

Share on facebook
  • Indian sprinter Dutee Chand, renowned as India’s fastest female athlete and holder of the national 100m record, has been handed a significant blow with a four-year ban following her failure in an out-of-competition dope test. 
  • The test revealed the presence of selective androgen receptor modulators (SARMs), leading to the decision to suspend her from competitive sports.
  • Chand’s ban, which commences from January 3, 2023, stems from her failed out-of-competition dope test for SARMs, which occurred on December 5, 2022.
  • The verdict, delivered by the National Anti-Doping Agency (NADA), found Chand in breach of “article 2.1 and 2.2 of the NADA,” resulting in a four-year ineligibility period under “article 10.2.1.1 of the NADA ADR 2021.”
Recent Post's
  • Pakistan shuts airspace and halts trade with India post-Pahalgam attack.

    Read More....
  • BHIM app introduces UPI Circle feature with partial delegation.

    Read More....
  • Pakistan terms diversion of Indus waters as ‘act of war’, threatens Simla Agreement abeyance.

    Read More....
  • Tamil Nadu bans raw egg-based mayonnaise for a year due to health risks.

    Read More....
  • Sports certificates now available via DigiLocker: Launched by Union Minister Mandaviya.

    Read More....
  • World Bank revises India’s 2025-26 GDP growth forecast to 6.3%.

    Read More....
  • US imposes fresh sanctions on Iran’s energy sector amid nuclear talk uncertainty.

    Read More....
  • Klaus Schwab resigns as WEF Chairman after five decades; interim chair appointed.

    Read More....
  • UNESCO adds 16 new Global Geoparks, bringing total to 229 across 50 countries.

    Read More....
  • World Immunization Week (April 24–30) promotes vaccine awareness to protect all age groups.

    Read More....